E-LIB Suche - Ergebnisse für: Kjaer, Magnus Ruud

1

0512 ABED: Automatic Sleep-Disordered Breathing Event Detec..:

Kjaer, Magnus Ruud ; Hanif, Umaer ; Brink-Kjaer, Andreas.
SLEEP. 47 (2024) Supplement_1 - p. A220-A220 , 2024

Link: https://doi.org/10.1093/..

2

Danish registry study showed increased incidence of paediat..:

Herrlin Jensen, Alice ; Jensen, Jakob Schmidt ; Kjær, Eva Ruud..
Acta Paediatrica. 109 (2020) 12 - p. 2727-2728 , 2020

Link: https://doi.org/10.1111/..

3

The metabotropic glutamate mGluR5 receptor agonist CHPG sti..:

Ploj, Karolina ; Albery-Larsdotter, Sara ; Arlbrandt, Susanne...
NeuroReport. 21 (2010) 10 - p. 704-708 , 2010

Link: https://doi.org/10.1097/..

4

Early Clinical Experience With AZD4831, A Novel Myeloperoxi..:

Nelander, Karin ; Lagerstrom‐Fermer, Maria ; Amilon, Carl...
Clinical and Translational Science. 14 (2021) 3 - p. 812-819 , 2021

Link: https://doi.org/10.1111/..

5

Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coron..:

Anttila, Vesa ; Saraste, Antti ; Knuuti, Juhani...
Molecular Therapy - Methods & Clinical Development. 18 (2020) - p. 464-472 , 2020

Link: https://doi.org/10.1016/..

6

Design and rationale of FLAVOUR: A phase IIa efficacy study..:

Prescott, Eva ; Pernow, John ; Saraste, Antti...
Contemporary Clinical Trials Communications. 19 (2020) - p. 100629 , 2020

Link: https://doi.org/10.1016/..

7

Intradermal delivery of modified mRNA encoding VEGF-A in pa..:

Gan, Li-Ming ; Lagerström-Fermér, Maria ; Carlsson, Leif G....
Nature Communications. 10 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

8

Safety, tolerability, pharmacokinetics and effect on serum ..:

Gan, Li‐Ming ; Lagerström‐Fermér, Maria ; Ericsson, Hans...
British Journal of Clinical Pharmacology. 85 (2019) 4 - p. 762-770 , 2019

Link: https://doi.org/10.1111/..

9

Safety, Tolerability, and Pharmacokinetics of the Mineraloc..:

Whittaker, Andrew ; Kragh, Åsa M. ; Hartleib‐Geschwindner, Judith...
Clinical and Translational Science. 13 (2019) 2 - p. 275-283 , 2019

Link: https://doi.org/10.1111/..

10

Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunte..:

Ericsson, Hans ; Nelander, Karin ; Heijer, Maria...
Clinical Pharmacology in Drug Development. 9 (2019) 3 - p. 411-421 , 2019

Link: https://doi.org/10.1002/..

11

Exploring the insulin secretory properties of the PGD2-GPR4..:

Skrtic, Stanko ; Tyrberg, Björn ; Broberg, Malin...
PLOS ONE. 13 (2018) 12 - p. e0208998 , 2018

Link: https://doi.org/10.1371/..

12

Initial Clinical Experience with AZD5718, a Novel Once Dail..:

Ericsson, Hans ; Nelander, Karin ; Lagerstrom‐Fermer, Maria...
Clinical and Translational Science. 11 (2018) 3 - p. 330-338 , 2018

Link: https://doi.org/10.1111/..

13

Clinical safety, tolerability, pharmacokinetics and effects..:

Erlandsson, Fredrik ; Albayaty, Muna ; Chialda, Ligia...
British Journal of Clinical Pharmacology. 84 (2018) 7 - p. 1486-1493 , 2018

Link: https://doi.org/10.1111/..

14

Estimands: discussion points from the PSI estimands and sen..:

Phillips, Alan ; Abellan‐Andres, Juan ; Soren, Andersen...
Pharmaceutical Statistics. 16 (2016) 1 - p. 6-11 , 2016

Link: https://doi.org/10.1002/..

15

Effects of melagatran, the active form of the oral direct t..:

Boström, Stig L ; Hansson, Göran FH ; Kjaer, Magnus.
Blood Coagulation & Fibrinolysis. 14 (2003) 5 - p. 457-462 , 2003

Link: https://doi.org/10.1097/..